Kyedae Acute Myeloid Leukemia Cancer: The content creator Kyedae for 100 Thieves shared that she’s preparing to undergo treatment for acute myeloid leukemia (AML), a form of cancer affecting the blood and bone marrow.
Acknowledging the uncertainty of her body’s response to treatment, Kyedae mentioned that her streaming schedule might experience irregularities.
Support and well-wishes flooded in from fellow gaming personalities, content creators, the Valorant community, and her dedicated fanbase, all rallying around her on social media platforms.
Fellow streamers Jeremy “Disguised Toast” Wang and Christina “Tina” Kenyon extended their hopes for a swift recovery.
Valorant professionals Trent “trent” Cairns and Nathan “leaf” Orf encouraged her to prioritize rest and reassured her that streaming commitments could take a backseat.
100 Thieves, her affiliation, assured Kyedae of their unwavering support, pledging to stand by her throughout her journey.
AML is typically diagnosed in older adults, with an average age of 68 at diagnosis, as reported by the American Cancer Society.
Kyedae had just returned from supporting her fiancé, Tyson “TenZ” Ngo, and his Sentinels team at VCT LOCK//IN in São Paulo, Brazil. The couple, who started dating in 2020 and got engaged in August the following year, received immense love and appreciation from the Valorant community.
At only 21 years old, Kyedae has risen to prominence as one of the leading Valorant streamers worldwide, garnering an impressive 2.1 million followers on Twitch.
Demonstrating remarkable progress in her gameplay, she achieved Immortal I ranking late last year.
As of now, Kyedae’s appearance is anticipated at CONQuest Festival 2023, where she is listed as a prominent guest for the Philippines-based event scheduled from June 2 to 4. Having been an integral part of the convention in the previous year, she connected with fans and immersed herself in Filipino culture.
What is Acute Myeloid Leukemia?
Acute Myeloid Leukemia (AML) is a type of blood cancer that starts in the bone marrow and affects the production of normal blood cells.
Definition and explanation
Acute Myeloid Leukemia (AML) is a type of blood and bone marrow cancer that develops rapidly. The condition starts in the bone marrow where new blood cells are produced, altering the process by which white blood cells mature.
Instead of growing into healthy white blood cells, they metamorphose into abnormal leukemia cells that can’t perform their job efficiently. These immature leukemia cells start to accumulate in the bloodstream and bone marrow, impinging on the production of normal blood cells.
Consequently, an individual with AML may experience symptoms such as fatigue, frequent infections or easy bruising due to a shortage of regular healthy blood components like red and white cells or platelets respectively.
Different subtypes
Acute Myeloid Leukemia (AML) is a type of blood cancer that can be further classified into different subtypes. These subtypes are based on the specific cell type in which the leukemia starts and how mature those cells are.
The most common AML subtype is called “de novo,” which means it arises from normal bone marrow cells. Another subtype is called “secondary AML” and occurs as a result of certain risk factors like exposure to radiation or chemotherapy.
There are also other less common subtypes, such as therapy-related AML and myelodysplastic syndrome-related AML. Understanding these different subtypes helps doctors determine the best treatment approach for each individual case.
Identifying the specific subtype of AML is crucial because it affects treatment options and prognosis for patients. Treatment plans may vary depending on the subtype, with some requiring more aggressive therapies than others.
Factors that can increase the risk
Certain factors can increase the risk of developing acute myeloid leukemia (AML). These include exposure to high levels of radiation or certain chemicals, such as benzene. Having a history of chemotherapy or radiation therapy for other types of cancer can also increase the risk.
In addition, certain genetic disorders, such as Down syndrome and Fanconi anemia, are associated with a higher likelihood of developing AML.
Symptoms and Diagnosis
Common symptoms of acute myeloid leukemia include fatigue, shortness of breath, frequent infections, easy bruising or bleeding, and pale skin. Diagnostic tests and procedures used to confirm AML may include blood tests, bone marrow biopsy, genetic testing, and imaging studies.
Common symptoms
Common symptoms of acute myeloid leukemia include fatigue, shortness of breath, and frequent infections. Other noticeable symptoms may include bruising or bleeding easily, pale skin, joint pain, and swollen lymph nodes.
Some individuals with acute myeloid leukemia experience flu-like symptoms such as fever, chills, and night sweats. It is important to note that these symptoms can vary from person to person and it is always best to consult a healthcare professional for an accurate diagnosis.
Diagnostic tests and procedures
Diagnostic tests and procedures play a crucial role in the diagnosis of acute myeloid leukemia (AML). To confirm the presence of AML, doctors may order blood tests to check for abnormal levels of white blood cells, red blood cells, and platelets.
Additionally, they may perform a bone marrow biopsy, where a small sample of bone marrow is taken from the hipbone or breastbone and analyzed for cancerous cells. Other diagnostic tools include imaging tests like X-rays or CT scans to determine if leukemia has spread to other parts of the body.
These tests help healthcare professionals accurately diagnose AML and develop an appropriate treatment plan tailored to each patient’s needs.
It is important for individuals experiencing symptoms related to AML or those with risk factors such as previous exposure to chemotherapy or radiation therapy to undergo these diagnostic tests promptly.